1972
K. N. Patel et al.
LETTER
Table 2 Oxidative Desulfurization of the Bisdiarylthioureaa
(continued)
Kennedy, J.; Kuipers, P.; Okonkwo, G.; Schrier, D.; Wright,
C. J. Med. Chem. 1993, 36, 1802. (d) Kumar, D.; Patel, G.;
Chavers, K.; Chang, K.; Shah, K. Eur. J. Med. Chem. 2011,
3085. (e) Aggarwal, N.; Kumar, R.; Dureja, P.; Khurana, J.
Chem. Biol. Drug Des. 2012, 79, 384.
S
S
HN
R
N
N
NH
R
PhI (2 equiv)
H
H
(2) (a) Dumciute, J.; Martynaitis, V.; Holzer, W.; Manelinckx,
S.; De Kimpe, N.; Sacaus, A. Tetrahedron 2006, 62, 3309.
(b) Dolman, S.; Gosselin, F.; Shea, P.; Davies, I. J. Org.
Chem. 2006, 71, 9548; and references cited therein.
(c) Demina, M.; Sarapulova, G.; Borisova, A.; Larina, L.;
Medvedeva, A. Russ. J. Org. Chem. 2003, 10, 1522.
(d) Rostom, S.; Shalaby, M.; El-Demellawy, M. Eur. J. Med.
Chem. 2003, 959. (e) Yale, H.; Losee, K. J. Med. Chem.
1966, 9, 478.
Oxone® (4 equiv)
Et3N (2 equiv)
MeOH
R
R
3a–d
N
N
N
N
H
S
H
4a–d
(3) Ghosh, H.; Yella, R.; Nath, J.; Patel, B. Eur. J. Org. Chem.
2008, 6189.
Entry
Substrate 3
Product 4
Yield (%)b
(4) Chaudhari, P.; Pathare, S.; Akamanchi, K. J. Org. Chem.
2012, 77, 3716.
(5) Zagulyaeva, A.; Banek, C.; Yusubov, M.; Zhdakin, V. Org.
Lett. 2010, 12, 4644.
S
S
HN
Cl
N
H
N
H
NH
(6) Typical Procedure for the Oxidative Desulfurization
A mixture of Oxone® (4 equiv) and iodobenzene (2 equiv) in
MeOH was stirred at r.t. for 20 min followed by addition of
Et3N (2 equiv) and substrate (1 equiv) at r.t. for 40 min. The
reaction mixture was diluted with H2O and then extracted
twice with EtOAc. The organic layer was washed succes-
sively with 10% NaHCO3 (2 × 20 mL), H2O (2 × 20 mL) and
dried over anhyd Na2SO4, filtered, and concen-trated under
reduced pressure to give the crude product. The product was
purified using silica gel column chromatography (30%
EtOAc–hexane).
3
4c
80
Cl
3c
S
S
HN
N
H
N
H
NH
4
4d
78
N-(4-Bromophenyl)-5-(4-chlorophenyl)-2-amino-1,3,4-
oxadiazole (2a)
3d
a Reaction conditions: Oxone® (4 mol), iodobenzene (2 mol), Et3N (2
mol), MeOH, r.t.
White solid, mp273–274 °C (lit.7a 272–274 °C). IR (KBr):
3318, 3032, 1551, 1435 cm–1. 1H NMR (300 MHz, CDCl3):
δ = 7.49–7.53 (m, 4 H),7.61 (d, 2 H), 7.89 (d, 2 H), 4.10 (s,
1 H).
b Isolated yields after column chromatography and structures were
confirmed by comparison of IR, 1H NMR, and mp with literature re-
ports.
N-5-Diphenyl-1,3,4-oxadiazole-2-amine (2i)
White solid, mp 218–219 °C (lit.7a 217–219 °C). IR (KBr):
3371, 3043, 1549, 1452 cm–1. 1H NMR (300 MHz, DMSO-
d6): δ = 6.92 (t, 1 H), 7.33 (dd, 2 H), 7.41 (m, 3 H), 7.58–7.62
(m, 2 H), 7.89 (m, 2 H), 8.91 (s, 1 H, NH).
In summary, we have utilized an in situ generated hyper-
valent iodine reagent system for the construction of the
azole heterocycles.
N2,N5-Bis(4-methoxyphenyl)-1,3,4-thiadiazole-2,5-
diamine (4a)
White solid, mp 234–236 °C (lit.7b 235–237 °C). IR (KBr):
3328, 1543, 1436, 1053 cm–1. 1H NMR (300 MHz, DMSO-
d6): δ = 3.74 (s, 6 H), 7.04 (d, 4 H), 7.38 (d, 4 H), 8.21 (s, 2
H).
Acknowledgment
We thank University Grant Commission, New Delhi, India for pro-
viding fellowships to KNP and NCJ under the Special Assistant
Programme (UGC-SAP) and to PBJ under Rajiv Gandhi National
Fellowship programme (UGC-RGNF).
N2,N5-Diphenyl-1,3,4-thiadiazole-2,5-diamine (4d)
White solid, mp 238–240 °C (lit.7c 239–242 °C). IR (KBr):
3335, 1548, 1424, 1161 cm–1. 1H NMR (300 MHz, DMSO-
d6): δ = 6.78 (d, 2 H), 7.15–7.47 (m, 6 H), 8.37 (s, 2 H).
(7) (a) Simiti, I.; Ghiran, D.; Schwartz, I. Arch. Pharm. Ber.
Dtsch. Pharm. Ges. 1971, 304, 230. (b) Joshua, C.; Annie,
V. J. Indian Chem. Soc. 1990, 759. (c) Yella, R.; Khatun, N.;
Rout, S.; Patel, B. Org. Biomol. Chem. 2011, 3235.
References
(1) (a) Lewis, J. Nat. Prod. Rep. 2000, 57. (b) Jansen, M.; Rabe,
H.; Strehle, A.; Dieler, S.; Debus, F.; Dannhardt, G.; Akabas,
M.; Lüddens, H. J. Med. Chem. 2008, 51, 4430.
(c) Boschelli, D.; Connor, D.; Bornemeier, D.; Dyer, R.;
Synlett 2012, 23, 1970–1972
© Georg Thieme Verlag Stuttgart · New York